Author

Bi Zhou

h-index 5 View on Semantic Scholar

We have 1 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

A Dual-Targeting Biomimetic Nanozyme Triggering Hypoxia Relief and Macrophage Reprogramming for Synergistic HCC Immunochemotherapy

MRS treatment effectively reprogrammed the immune response by activating the STING/IRF3 signaling pathway, facilitating the shift of macrophages from a pro-tumor M2-like phenotype to an antitumor M1-like phenotype, resulting in robust tumor growth inhibition with negligible systemic toxicity.

Bi Zhou, Liang Xia, Gengyun Miao et al. · ACS Applied Nano Materials · 0 citations